Landaas & Company’s Bristol-Myers Squibb BMY Stock Holding History

Landaas & Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,373	Closed	-$131K	–	93
2018 Q2	$131K	Buy	+2,373	New	+$128K	0.1%	82
2018 Q1	–	Sell	-2,369	Closed	-$145K	–	88
2017 Q4	$145K	Buy	2,369 +2	+0.1%	+$125	0.13%	75
2017 Q3	$151K	Buy	+2,367	New	+$138K	0.13%	67

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Landaas & Company's BMY Position: Q3 2018 in Review

Landaas & Company sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 2,373 shares — an estimated $131K sold.

Landaas & Company first reported a position in BMY in Q3 2017 and held it in 3 quarters. The position peaked at $151K in Q3 2017. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

Landaas & Company reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
Landaas & Company sold 2,373 Bristol-Myers Squibb shares in Q3 2018, an estimated $131K.
Landaas & Company first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 3 quarters.
Landaas & Company's Bristol-Myers Squibb position peaked at $151K in Q3 2017.
1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.